State Requirement Info
Searching all 4 courses
1
https://www.physicaltherapy.com/pt-ceus/course/glp-1-weight-loss-medications-4952
GLP-1 Weight Loss Medications: What Healthcare Providers Should Know!
The GLP-1 medications have become a popular treatment for individuals with type II diabetes or obesity. Healthcare providers must understand these medications, including the benefits, adverse effects, and contraindications. For some individuals, these medications can have consequences such as loss of lean mass loss, which can affect their function, health, and longevity. This presentation will provide an evidence-based update on this topic.
auditory, textual, visual
GLP-1 Weight Loss Medications: What Healthcare Providers Should Know!
Presented by Scott Cheatham, PT, DPT, PhD, OCS, ATC, CSCS
Course: #4952Level: Advanced2 Hours
AK/2.0; AL/2.0; AR/2.0; AZ/2.0; BOC/2.0; CA/2.0; CO/2.0; CT/2.0; DC/2.0; DE/2.0; FL/2.0; GA/2.0; HI/2.0; IA/2.0; IACET/0.2; ID/2.0; IL/2.0; IN/2.0; KS/2.0; KY/2.0 Category 2; MA/2.0; ME/2.0; MI/2.0; MO/2.0; MS/2.0; MT/2.0; NC/2.0; ND/2.0; NE/2.0; NH/2.0; NY/2.0; OK/2.0; OR/2.0; PA/2.0; RI/2.0; SC/2.0; SD/2.0; TN/2.0; TX/2.0; UT/2.0; VA/2.0; VT/2.0; WA/2.0; WI/2.0; WY/2.0
The GLP-1 medications have become a popular treatment for individuals with type II diabetes or obesity. Healthcare providers must understand these medications, including the benefits, adverse effects, and contraindications. For some individuals, these medications can have consequences such as loss of lean mass loss, which can affect their function, health, and longevity. This presentation will provide an evidence-based update on this topic.
2
https://www.physicaltherapy.com/pt-ceus/course/high-alert-medications-in-home-3966
High-Alert Medications in Home Health
The focus of this webinar is on three classes of high-alert medications that have the potential for patient harm if used incorrectly. The indications, mechanism of action, side effects, and implications for physical therapy for each medication class is discussed. This course is directly related to the practice of physical therapy and is therefore appropriate for the PT/PTA.
auditory, textual, visual
High-Alert Medications in Home Health
Presented by Melissa Bednarek, PT, DPT, PhD, CCS
Course: #3966Level: Intermediate2 Hours
AK/2.0; AL/2.0; AR/2.0; AZ/2.0; CA/2.0; CO/2.0; CT/2.0; DC/2.0; DE/2.0; FL/2.0; GA/2.0; HI/2.0; IA/2.0; IACET/0.2; ID/2.0; IL/2.0; IN/2.0; KS/2.0; KY/2.0 Category 2; MA/2.0; ME/2.0; MI/2.0; MO/2.0; MS/2.0; MT/2.0; NC/2.0; ND/2.0; NE/2.0; NH/2.0; NY/2.0; OR/2.0; PA/2.0; RI/2.0; SC/2.0; SD/2.0; TN/2.0; TX/2.0; UT/2.0; VA/2.0; VT/2.0; WA/2.0; WI/2.0; WY/2.0
The focus of this webinar is on three classes of high-alert medications that have the potential for patient harm if used incorrectly. The indications, mechanism of action, side effects, and implications for physical therapy for each medication class is discussed. This course is directly related to the practice of physical therapy and is therefore appropriate for the PT/PTA.
3
https://www.physicaltherapy.com/pt-ceus/course/oncologic-pharmacology-for-rehabilitation-professional-3894
Oncologic Pharmacology for the Rehabilitation Professional
A vast array of drugs are used to treat patients with cancer. This webinar will introduce the attendee to the basic pharmacology of these drugs, the mechanism of action of different classes of these drugs, and frequently observed adverse effects of these drugs. This course is directly related to the practice of physical therapy and is therefore appropriate for the PT/PTA.
auditory, textual, visual
Oncologic Pharmacology for the Rehabilitation Professional
Presented by Stephen Morris, PT, PhD, FACSM
Course: #3894Level: Intermediate2 Hours
AK/2.0; AL/2.0; AR/2.0; AZ/2.0; CA/2.0; CO/2.0; CT/2.0; DC/2.0; DE/2.0; FL/2.0; GA/2.0; HI/2.0; IA/2.0; IACET/0.2; ID/2.0; IL/2.0; IN/2.0; KS/2.0; KY/2.0 Category 2; MA/2.0; ME/2.0; MI/2.0; MO/2.0; MS/2.0; MT/2.0; NC/2.0; ND/2.0; NE/2.0; NH/2.0; NY/2.0; OR/2.0; PA/2.0; RI/2.0; SC/2.0; SD/2.0; TN/2.0; TX/2.0; UT/2.0; VA/2.0; VT/2.0; WA/2.0; WI/2.0; WY/2.0
A vast array of drugs are used to treat patients with cancer. This webinar will introduce the attendee to the basic pharmacology of these drugs, the mechanism of action of different classes of these drugs, and frequently observed adverse effects of these drugs. This course is directly related to the practice of physical therapy and is therefore appropriate for the PT/PTA.
4
https://www.physicaltherapy.com/pt-ceus/course/geriatric-pharmacology-pt-role-and-3488
Geriatric Pharmacology: PT Role and Responsibilities
This course will look at issues related to geriatric pharmacology and PT role in pharmaceutical management; especially in the home health setting. Issues related to polypharmacy, adverse effects and aging systems as related to the PT plan of care will be presented through case scenarios. This course is directly related to the practice of physical therapy and is therefore appropriate for the PT/PTA.
auditory, textual, visual
Geriatric Pharmacology: PT Role and Responsibilities
Presented by JIll Heitzman, PT, DPT, GCS, NCS, CWS, CEEAA, FACCWS
Course: #3488Level: Intermediate2 Hours
AK/2.0; AL/2.0; AR/2.0; AZ/2.0; CA/2.0; CO/2.0; CT/2.0; DE/2.0; FL/2.0; GA/2.0; HI/2.0; IA/2.0; IACET/0.2; ID/2.0; IL/2.0; IN/2.0; KS/2.0; KY/2.0 Category 2; LA/2.0; MA/2.0; ME/2.0; MI/2.0; MO/2.0; MS/2.0; MT/2.0; NC/2.0; ND/2.0; NE/2.0; NH/2.0; NM/2.0; NY/2.0; OH/2.0; OR/2.0; PA/2.0; RI/2.0; SC/2.0; SD/2.0; TN/2.0; TX/2.0; UT/2.0; VA/2.0; VT/2.0; WA/2.0; WI/2.0; WV/2.0; WY/2.0
This course will look at issues related to geriatric pharmacology and PT role in pharmaceutical management; especially in the home health setting. Issues related to polypharmacy, adverse effects and aging systems as related to the PT plan of care will be presented through case scenarios. This course is directly related to the practice of physical therapy and is therefore appropriate for the PT/PTA.